Literature DB >> 18029128

Discrepancy between auditory brainstem responses, auditory steady-state responses, and auditory behavior in two patients with Pelizaeus-Merzbacher disease.

Manabu Tanaka1, Shin-Ichiro Hamano, Hideaki Sakata, Nodoka Adachi, Kimitaka Kaga, Hitoshi Osaka, Kenji Kurosawa.   

Abstract

We reported two cases of Pelizaeus-Merzbacher disease. Both cases visited our hospital manifesting horizontal nystagmoid movements present from birth, and delayed motor development. Magnetic resonance imaging of the brain showed diffuse dysmyelination of the cerebral white matter, and auditory brainstem response showed waves I and II but absence of all subsequent components. Conditioned orientation reflex (COR) audiometry showed poor reactions in an infantile case whose development was severely retarded, and who spoke no meaningful words. Auditory steady-state response (ASSR) was a helpful tool for identifying her auditory ability; thereafter, her communication skills improved naturally. The other case was mildly developmentally retarded, and the results of COR audiometry and ASSR were considered the same level. The discrepancy between results of these hearing tests may arise under the influence of developmental level of the case.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18029128     DOI: 10.1016/j.anl.2007.09.002

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  2 in total

1.  Auditory function in Pelizaeus-Merzbacher disease.

Authors:  Thierry Morlet; Kyoko Nagao; S Charles Bean; Sara E Mora; Sarah E Hopkins; Grace M Hobson
Journal:  J Neurol       Date:  2018-05-03       Impact factor: 4.849

2.  Identifying congenital hearing impairment: preliminary results from a comparative study using objective and subjective audiometric protocols.

Authors:  A Ciorba; S Hatzopoulos; J Petruccelli; M Mazzoli; A Pastore; K Kochanek; P Skarzynski; A Wlodarczyk; H Skarzynski
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-02       Impact factor: 2.124

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.